We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+2.83%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$823M
AUM Growth
+$71.1M
Cap. Flow
-$53M
Cap. Flow %
-6.44%
Top 10 Hldgs %
50.09%
Holding
190
New
61
Increased
39
Reduced
31
Closed
53

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$19.1M
2
MAC icon
Macerich
MAC
+$12.1M
3
EVA
Enviva Inc.
EVA
+$9.8M
4
OKTA icon
Okta
OKTA
+$8.15M
5
PEGI
Pattern Energy Group Inc. Class A
PEGI
+$7.71M

Top Sells

Rank Stock Value
1
RITM icon
Rithm Capital
RITM
+$19.4M
2
ZBH icon
Zimmer Biomet
ZBH
+$12.9M
3
ORCL icon
Oracle
ORCL
+$12.8M
4
URI icon
United Rentals
URI
+$10.4M
5
CIO
City Office REIT
CIO
+$10.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 40.54%
2 Healthcare 16.94%
3 Technology 10.73%
4 Utilities 8.3%
5 Materials 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
101
Vertex Pharmaceuticals
VRTX
$131B
$375K 0.05%
2,500
-16,000
-86% -$2.37M
WBA
102
DELISTED
Walgreens Boots Alliance
WBA
$363K 0.04%
+5,000
New +$352K
ADVM
103
DELISTED
Adverum Biotechnologies
ADVM
$350K 0.04%
+10,000
New +$329K
EGHT icon
104
8x8 Inc
EGHT
$266M
$338K 0.04%
24,000
-6,000
-20% -$82.9K
RGNX icon
105
Regenxbio
RGNX
$563M
$334K 0.04%
10,000
– –
NBIS
106
Nebius Group N.V.
NBIS
$61B
$328K 0.04%
10,000
-20,000
-67% -$653K
PTE
107
DELISTED
PolarityTE, Inc. Common Stock
PTE
$327K 0.04%
+564
New +$359K
ATRC icon
108
AtriCure
ATRC
$2.77B
$319K 0.04%
17,500
+2,500
+17% +$49.5K
TEAM icon
109
Atlassian
TEAM
$45.5B
$319K 0.04%
7,000
-12,000
-63% -$558K
ALDX icon
110
Aldeyra Therapeutics
ALDX
$80.8M
$306K 0.04%
45,000
+5,448
+14% +$35.9K
CY
111
DELISTED
Cypress Semiconductor
CY
$305K 0.04%
+20,000
New +$318K
FNSR
112
DELISTED
Finisar Corp
FNSR
$305K 0.04%
15,000
-202,500
-93% -$4.21M
GRDX
113
GridAI Technologies Corp
GRDX
$20.4M
$300K 0.04%
+1
New +$397K
RUN icon
114
CALL
Sunrun
RUN
$2.06B
$295K 0.04%
+50,000
New +$287K
NVDA icon
115
NVIDIA
NVDA
$5.27T
$290K 0.04%
60,000
-100,000
-63% -$497K
ALBO
116
DELISTED
Albireo Pharma Inc
ALBO
$289K 0.04%
+11,300
New +$287K
DERM
117
DELISTED
Dermira, Inc.
DERM
$278K 0.03%
10,000
– –
CERS icon
118
Cerus
CERS
$502M
$270K 0.03%
80,000
– –
OPCH icon
119
Option Care Health
OPCH
$3.52B
$262K 0.03%
22,500
+3,750
+20% +$37.9K
AKCA
120
DELISTED
Akcea Therapeutics Inc
AKCA
$260K 0.03%
15,000
+5,000
+50% +$98K
AMBA icon
121
Ambarella
AMBA
$3B
$235K 0.03%
+4,000
New +$222K
RPD icon
122
Rapid7
RPD
$695M
$224K 0.03%
+12,000
New +$222K
ACER
123
DELISTED
Acer Therapeutics Inc
ACER
$212K 0.03%
+15,300
New +$249K
ACGN
124
DELISTED
Aceragen Inc
ACGN
$211K 0.03%
+92
New +$210K
GYRE icon
125
Gyre Therapeutics
GYRE
$714M
$205K 0.02%
+2,000
New +$102K
3 4
5
6 7

Similar funds

RAM
Ramirez Asset Management New York $960M AUM 30.25% 1-Year Est. Return
JWBC
J.W. Burns & Co Dewitt, New York $959M AUM 25.08% 1-Year Est. Return
PL
Parthenon LLC Louisville, Kentucky $962M AUM 27.46% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return
WI
Wahed Invest New York $958M AUM 66.65% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $963M AUM 38.06% 1-Year Est. Return
ACP
Aviance Capital Partners Naples, Florida $963M AUM 32.56% 1-Year Est. Return

Ardsley Advisory Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Ardsley Advisory Partners held 190 positions worth $823M, up 9.5% from $752M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Ardsley Advisory Partners withdrew a net $53M in Q4 2017, closing 53 positions and reducing 31 holdings. Its most notable exit was Rithm Capital, an estimated $19.4M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Ardsley Advisory Partners opened a new position in Macerich worth $13M.

  • Ardsley Advisory Partners's largest Q4 2017 buy was Macerich: 198,500 shares worth $13M.
  • Ardsley Advisory Partners added most to AbbVie in Q4 2017, an estimated $19.1M increase.
  • Ardsley Advisory Partners's biggest Q4 2017 reduction was PARSLEY ENERGY INC, cutting an estimated $9.35M.
  • Ardsley Advisory Partners fully exited Rithm Capital in Q4 2017, selling an estimated $19.4M.
  • Ardsley Advisory Partners's ten largest holdings make up 50% of its $823M portfolio in Q4 2017.
  • Ardsley Advisory Partners opened 61 new positions and closed 53 in Q4 2017.
  • Ardsley Advisory Partners's portfolio value rose 9.5% quarter-over-quarter to $823M.

Based on Ardsley Advisory Partners's 13F filing for Q4 2017, filed 14 Feb 2018.